BIOMERIEUX (P.S.) O.N./ FR0013280286 /
| 11/8/2024 2:33:15 PM | Chg. -0.40 | Volume | Bid9:59:59 PM | Ask9:59:59 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 101.30EUR | -0.39% | 29 Turnover: 2,935.60 |
102.30Bid Size: 11 | 102.80Ask Size: 11 | 12.11 bill.EUR | 0.83% | 33.76 |
Assets
|
2010 IFRS in mill. EUR |
2011 IFRS in mill. EUR |
2012 IFRS in mill. EUR |
2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 340.1000 | 367 | 386.7000 | 404.8000 | 486.9000 | ||||||
| Intangible Assets | 122.7000 | 184.4000 | 157 | 149.7000 | 460.1000 | ||||||
| Long-Term Investments | 26.6000 | 26.9000 | 34.7000 | 31.9000 | 35.1000 | ||||||
| Fixed Assets | 731.2000 | 972.2000 | 942.2000 | 950.1000 | 1,528.3000 | ||||||
| Inventories | 179.5000 | 217.1000 | 245.9000 | 261.7000 | 299.2000 | ||||||
| Accounts Receivable | 403 | 447.1000 | 433.4000 | 420.5000 | 449.3000 | ||||||
| Cash and Cash Equivalents | 71.4000 | 42.7000 | 65.6000 | 428 | 119.7000 | ||||||
| Current Assets | 705.5000 | 777.9000 | 845.4000 | 1,196.2000 | 991.4000 | ||||||
| Total Assets | 1,448.7000 | 1,762.2000 | 1,833.2000 | 2,196.6000 | 2,580.5000 | ||||||
Liabilities
|
2010 IFRS in mill. EUR |
2011 IFRS in mill. EUR |
2012 IFRS in mill. EUR |
2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 128.9000 | 142.6000 | 145.1000 | 132.3000 | 188.9000 | ||||||
| Long-term debt | 7.5000 | 12.6000 | 9.8000 | 304.6000 | 305.7000 | ||||||
| Liabilities to Banks | 47.1000 | 173.9000 | 114 | 403.1000 | 369.2000 | ||||||
| Provisions | 70.8000 | 88.4000 | 99.5000 | 119.1000 | 261.6000 | ||||||
| Liabilities | 472.6000 | 658.8000 | 633.1000 | 929.3000 | 1,191.9000 | ||||||
| Share Capital | 12 | 12 | 12 | 12 | 12 | ||||||
| Total Equity | 971.7000 | 1,095.4000 | 1,193.4000 | 1,260.8000 | 1,380.9000 | ||||||
| Minority Interests | 4.4000 | 8 | 6.8000 | 6.5000 | 7.8000 | ||||||
| Total liabilities equity | 1,448.7000 | 1,762.2000 | 1,833.2000 | 2,196.6000 | 2,580.5000 | ||||||
Income Statement
|
2010 IFRS in mill. EUR |
2011 IFRS in mill. EUR |
2012 IFRS in mill. EUR |
2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 1,357 | 1,427.2000 | 1,569.8000 | 1,587.9000 | 1,698.4000 | ||||||
| Depreciation (total) | - | - | - | - | - | ||||||
| Operating Result | 244 | 245.4000 | 235 | 257.5000 | 203.6000 | ||||||
| Interest Income | - | - | - | - | - | ||||||
| Income Before Taxes | 241.4000 | 237.7000 | 223.6000 | 243.5000 | 187.2000 | ||||||
| Income Taxes | -81.4000 | -77.2000 | -89.4000 | -78.8000 | -51.7000 | ||||||
| Minority Interests Profit | -1.3000 | -2.3000 | .1000 | -.4000 | -.6000 | ||||||
| Net Income | 158.7000 | 158.2000 | 134.4000 | 164.3000 | 134.9000 | ||||||
Per Share
Cash Flow
|
2010 IFRS in mill. EUR |
2011 IFRS in mill. EUR |
2012 IFRS in mill. EUR |
2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 199 | 216.6000 | 258.5000 | 240.5000 | 298.3000 | ||||||
| Cash Flow from Investing Activities | -141.2000 | -325.2000 | -130.4000 | -128.6000 | -502.7000 | ||||||
| Cash Flow from Financing | -45.8000 | 17.3000 | -56.2000 | 250.6000 | -83.4000 | ||||||
| Decrease / Increase in Cash | 12 | -91.3000 | 71.9000 | 362.5000 | -287.8000 | ||||||
| Employees | 6,306 | 7,014 | 7,285 | 7,724 | 8,695 | ||||||
